questionsmedicales.fr
Tumeurs
Tumeurs par type histologique
Tumeurs épithéliales épidermoïdes et glandulaires
Carcinomes
Adénocarcinome
Adénocarcinome folliculaire
Adénocarcinome folliculaire : Questions médicales fréquentes
Diagnostic
5
Carcinome
Thyroïde
Biopsie
Échographie
Scintigraphie
Aiguille fine
Marqueurs tumoraux
Thyroglobuline
Surveillance
Imagerie
Échographie
Thyroïde
IRM
Scanner
Extension du cancer
Symptômes
5
Symptômes
Masse cervicale
Difficultés à avaler
Signes d'alerte
Changements de voix
Toux
Âge
Symptômes
Personnes âgées
Symptômes
Masse palpable
Cancer
Prévention
5
Régime alimentaire
Iode
Santé thyroïdienne
Antécédents familiaux
Risque
Cancer de la thyroïde
Environnement
Radiations
Risque
Examens réguliers
Détection précoce
Anomalies
Traitements
5
Chirurgie
Radiothérapie
Hormonothérapie
Chirurgie
Traitement
Étendue du cancer
Effets secondaires
Fatigue
Troubles hormonaux
Radiothérapie
Efficacité
Chirurgie
Suivi
Examens réguliers
Thyroglobuline
Complications
5
Complications
Récidive
Problèmes hormonaux
Gestion
Suivi médical
Traitement
Qualité de vie
Complications
Soutien
Complications à long terme
Troubles thyroïdiens
Persistants
Fréquence
Complications
Récidive
Facteurs de risque
5
Facteurs de risque
Radiations
Antécédents familiaux
Maladies thyroïdiennes
Thyroïdite
Risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Adénocarcinome folliculaire : Questions médicales les plus fréquentes",
"headline": "Adénocarcinome folliculaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Adénocarcinome folliculaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-23",
"dateModified": "2026-04-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Adénocarcinome folliculaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Adénocarcinome",
"url": "https://questionsmedicales.fr/mesh/D000230",
"about": {
"@type": "MedicalCondition",
"name": "Adénocarcinome",
"code": {
"@type": "MedicalCode",
"code": "D000230",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.557.470.200.025"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Adénocarcinome folliculaire",
"alternateName": "Adenocarcinoma, Follicular",
"code": {
"@type": "MedicalCode",
"code": "D018263",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sandrine Roulland",
"url": "https://questionsmedicales.fr/author/Sandrine%20Roulland",
"affiliation": {
"@type": "Organization",
"name": "Aix Marseille University, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy, Marseille, France."
}
},
{
"@type": "Person",
"name": "Xiaomei Wang",
"url": "https://questionsmedicales.fr/author/Xiaomei%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Animal Biotechnology, Ministry of Agriculture, College of Veterinary Medicine, Northwest Agriculture and Forestry University, Yangling 712100, Shaanxi, China."
}
},
{
"@type": "Person",
"name": "Ying Wang",
"url": "https://questionsmedicales.fr/author/Ying%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Animal Biotechnology, Ministry of Agriculture, College of Veterinary Medicine, Northwest Agriculture and Forestry University, Yangling 712100, Shaanxi, China."
}
},
{
"@type": "Person",
"name": "Yong Zhang",
"url": "https://questionsmedicales.fr/author/Yong%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Animal Biotechnology, Ministry of Agriculture, College of Veterinary Medicine, Northwest Agriculture and Forestry University, Yangling 712100, Shaanxi, China."
}
},
{
"@type": "Person",
"name": "Fusheng Quan",
"url": "https://questionsmedicales.fr/author/Fusheng%20Quan",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Animal Biotechnology, Ministry of Agriculture, College of Veterinary Medicine, Northwest Agriculture and Forestry University, Yangling 712100, Shaanxi, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Intratumoural metastasis of primary lung adenocarcinoma to non-invasive follicular thyroid neoplasm with papillary-like nuclear features.",
"datePublished": "2023-05-22",
"url": "https://questionsmedicales.fr/article/37216302",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.32074/1591-951X-780"
}
},
{
"@type": "ScholarlyArticle",
"name": "Management of follicular thyroid carcinoma.",
"datePublished": "2024-10-16",
"url": "https://questionsmedicales.fr/article/39419099",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1530/ETJ-24-0146"
}
},
{
"@type": "ScholarlyArticle",
"name": "Proteomics profile in encapsulated follicular patterned thyroid neoplasms.",
"datePublished": "2024-07-16",
"url": "https://questionsmedicales.fr/article/39013964",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-67079-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Study of non-invasive follicular thyroid neoplasm: A borderline entity.",
"datePublished": "2024-09-19",
"url": "https://questionsmedicales.fr/article/39412902",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4103/jcrt.jcrt_2327_22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Follicular carcinoma of the thyroid presenting as metastasis in the wall of an arachnoid cyst.",
"datePublished": "2023-10-31",
"url": "https://questionsmedicales.fr/article/37907313",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2023-255865"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tumeurs",
"item": "https://questionsmedicales.fr/mesh/D009369"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs par type histologique",
"item": "https://questionsmedicales.fr/mesh/D009370"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs épithéliales épidermoïdes et glandulaires",
"item": "https://questionsmedicales.fr/mesh/D009375"
},
{
"@type": "ListItem",
"position": 5,
"name": "Carcinomes",
"item": "https://questionsmedicales.fr/mesh/D002277"
},
{
"@type": "ListItem",
"position": 6,
"name": "Adénocarcinome",
"item": "https://questionsmedicales.fr/mesh/D000230"
},
{
"@type": "ListItem",
"position": 7,
"name": "Adénocarcinome folliculaire",
"item": "https://questionsmedicales.fr/mesh/D018263"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Adénocarcinome folliculaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Adénocarcinome folliculaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Adénocarcinome folliculaire",
"description": "Comment diagnostiquer un adénocarcinome folliculaire ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels marqueurs tumoraux sont associés ?\nQuelle imagerie est recommandée ?\nComment évaluer l'extension du cancer ?",
"url": "https://questionsmedicales.fr/mesh/D018263#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Adénocarcinome folliculaire",
"description": "Quels sont les symptômes courants ?\nY a-t-il des signes d'alerte ?\nComment se manifeste la douleur ?\nLes symptômes varient-ils selon l'âge ?\nPeut-on avoir des symptômes sans masse visible ?",
"url": "https://questionsmedicales.fr/mesh/D018263#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Adénocarcinome folliculaire",
"description": "Peut-on prévenir l'adénocarcinome folliculaire ?\nLe régime alimentaire joue-t-il un rôle ?\nLes antécédents familiaux influencent-ils le risque ?\nFaut-il éviter certains environnements ?\nLes examens réguliers sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D018263#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Adénocarcinome folliculaire",
"description": "Quels traitements sont disponibles ?\nLa chirurgie est-elle toujours nécessaire ?\nQuels sont les effets secondaires des traitements ?\nLa radiothérapie est-elle efficace ?\nQuelles sont les options de suivi après traitement ?",
"url": "https://questionsmedicales.fr/mesh/D018263#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Adénocarcinome folliculaire",
"description": "Quelles complications peuvent survenir ?\nComment gérer les complications ?\nLes complications affectent-elles la qualité de vie ?\nY a-t-il des complications à long terme ?\nLes complications sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D018263#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Adénocarcinome folliculaire",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes maladies thyroïdiennes augmentent-elles le risque ?\nLe sexe joue-t-il un rôle dans le risque ?\nL'alimentation influence-t-elle le risque ?",
"url": "https://questionsmedicales.fr/mesh/D018263#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un adénocarcinome folliculaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par échographie, biopsie et analyses sanguines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'échographie, la scintigraphie et la biopsie à l'aiguille fine."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont associés ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le marqueur thyroglobuline est souvent utilisé pour surveiller la maladie."
}
},
{
"@type": "Question",
"name": "Quelle imagerie est recommandée ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échographie cervicale est la méthode d'imagerie de choix pour évaluer la thyroïde."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'extension du cancer ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM et le scanner peuvent être utilisés pour évaluer l'extension locale et à distance."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent une masse cervicale, des difficultés à avaler et des douleurs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes d'alerte ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des changements dans la voix ou une toux persistante peuvent être des signes d'alerte."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la douleur ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "La douleur peut être localisée au cou et parfois irradier vers les oreilles."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus subtils chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans masse visible ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent présenter des symptômes sans masse palpable."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'adénocarcinome folliculaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Le régime alimentaire joue-t-il un rôle ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un régime riche en iode peut être bénéfique pour la santé thyroïdienne."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer de la thyroïde augmentent le risque."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certains environnements ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition à des radiations peut réduire le risque de cancer."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter précocement des anomalies."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la radiothérapie et l'hormonothérapie."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle toujours nécessaire ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est souvent le traitement principal, mais dépend de l'étendue du cancer."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure fatigue, douleurs et troubles hormonaux."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie peut être efficace, surtout après la chirurgie."
}
},
{
"@type": "Question",
"name": "Quelles sont les options de suivi après traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le suivi inclut des examens réguliers et des dosages de thyroglobuline."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la récidive du cancer et des problèmes hormonaux."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite un suivi médical régulier et un traitement approprié."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent affecter la qualité de vie et nécessiter un soutien."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications à long terme ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications à long terme peuvent inclure des troubles thyroïdiens persistants."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications varient, mais la récidive est une préoccupation fréquente."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition aux radiations, l'âge et les antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout après 60 ans."
}
},
{
"@type": "Question",
"name": "Les maladies thyroïdiennes augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies thyroïdiennes, comme la thyroïdite, peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle dans le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes sont plus souvent touchées que les hommes par ce type de cancer."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une carence en iode peut augmenter le risque de cancer de la thyroïde."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 14/04/2026
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Aix Marseille University, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
Publications dans "Adénocarcinome folliculaire" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Animal Biotechnology, Ministry of Agriculture, College of Veterinary Medicine, Northwest Agriculture and Forestry University, Yangling 712100, Shaanxi, China.
Publications dans "Adénocarcinome folliculaire" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Animal Biotechnology, Ministry of Agriculture, College of Veterinary Medicine, Northwest Agriculture and Forestry University, Yangling 712100, Shaanxi, China.
Publications dans "Adénocarcinome folliculaire" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Animal Biotechnology, Ministry of Agriculture, College of Veterinary Medicine, Northwest Agriculture and Forestry University, Yangling 712100, Shaanxi, China.
Publications dans "Adénocarcinome folliculaire" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Animal Biotechnology, Ministry of Agriculture, College of Veterinary Medicine, Northwest Agriculture and Forestry University, Yangling 712100, Shaanxi, China.
Publications dans "Adénocarcinome folliculaire" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, Japan. miyoshi_hiroaki@med.kurume-u.ac.jp.
Publications dans "Adénocarcinome folliculaire" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, Japan.
Publications dans "Adénocarcinome folliculaire" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, Japan.
Publications dans "Adénocarcinome folliculaire" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, Japan.
Publications dans "Adénocarcinome folliculaire" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, Japan.
Publications dans "Adénocarcinome folliculaire" :
2 publications dans cette catégorie
Affiliations :
Department of Hematology, Peking Union Medical College Hospital, Beijing, People's Republic of China.
Publications dans "Adénocarcinome folliculaire" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, 211166, China.
Publications dans "Adénocarcinome folliculaire" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China.
Publications dans "Adénocarcinome folliculaire" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, China.
Publications dans "Adénocarcinome folliculaire" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Cancer Center, Ward I, Peking University Cancer Hospital & Institute, Beijing, China.
Publications dans "Adénocarcinome folliculaire" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China.
Publications dans "Adénocarcinome folliculaire" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China.
Publications dans "Adénocarcinome folliculaire" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China.
Publications dans "Adénocarcinome folliculaire" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Cancer Center, Ward I, Peking University Cancer Hospital & Institute, Beijing, China.
Publications dans "Adénocarcinome folliculaire" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China.
Publications dans "Adénocarcinome folliculaire" :
Metastasis to the thyroid gland is very uncommon with an incidence of 2-3% of all thyroid malignancies. A higher incidence is noted in autopsy studies indicating incidental detection. However, tumour-...
Follicular thyroid carcinoma (FTC) is the second most common histological type of thyroid carcinoma. This review aims to summarize the available evidence and guidelines and provide an updated consensu...
Diagnosing encapsulated follicular-patterned thyroid tumors like Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma (IEFVPTC), Non-invasive Follicular Thyroid Neoplasm with Papill...
Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is a newly added entity in the fourth edition of the WHO Classification of Tumors of Endocrine Organs (2017). It i...
To study the recently diagnosed entity, NIFTP, as not many cases have been reported of the same....
A retrospective analysis of all thyroid neoplasms received in the Department of Pathology of our institute over two years was done. Out of the 188 cases that we reported, 38 were of non-invasive folli...
Thirty-two patients were female, whereas six patients were male. Thirty-five patients presented with solitary thyroid nodule and the others had an ill-defined thyroid swelling. Thirty-four patients ha...
It is crucial to carefully study the histopathological features of solitary thyroid swellings and correlate with clinical and radiological findings. The recently added diagnostic category of NIFTP hel...
The brain is an uncommon site for metastases of differentiated thyroid carcinoma with the most common location being cerebral hemispheres, followed by cerebellum and pituitary gland. Metastasis in the...
Although pediatric thyroid tumors have many similarities to those occurring in adults, significant differences are also recognized. For example, although thyroid nodules in children are much less comm...
To assess the molecular profile of follicular cell-derived thyroid carcinomas (FCDTCs) and correlate the identified mutations with the clinical and pathological features of the affected patients....
Cross-sectional study of tumor samples from 100 adult patients diagnosed with FCDTC between 2010 and 2019. The patients' clinical and pathological data were collected. Genomic DNA was extracted from f...
The patients' mean age was 39 years. In all, 82% of the tumors were classic papillary thyroid carcinomas. Overall, 54 (54%) tumor samples yielded satisfactory results on next-generation sequencing (NG...
We described herein seven non-hotspot/novel variants in the...
Thyroid cancer is one of the most frequently reported endocrine system malignancies. It is difficult to distinguish follicular thyroid cancer (FTC) from follicular thyroid adenoma (FTA) during patholo...
We used 165 tissue samples, including FTC (n = 58), thyroid tumors of uncertain malignant potential (TT-UMP, n = 40), and FTA (n = 67), to explore the differences in SLC5A8 methylation and mRNA transc...
The SLC5A8 methylation positive rate was higher in patients with thyroglobulin ≥ 40 μg/l and Chol ≥ 5.17 mmol/l, and it was higher in patients with FTC (n = 42, 72.4%) than those with FTA (n = 27, 40....
Our current study indicates that SLC5A8 gene methylation occurs more commonly in patients with FTC than in those with FTA. The differences in SLC5A8 methylation and expression among FTA, FTC, and TT-U...
To assess the feasibility, efficacy, and safety of microwave ablation in treating follicular thyroid neoplasms and suspicious follicular thyroid neoplasms....
In this retrospective study, the data of patients treated with microwave ablation for follicular neoplasms from December 2016 to January 2024 were summarized. The changes in nodule size, volume, techn...
Seventy-four patients (15 men, 59 women; mean age 46.3 ± 15.2 years) with follicular neoplasms were included. Over a median follow-up of 13 months, complete ablation was achieved, giving a 100% techni...
Initial findings suggest microwave ablation is an effective and safe treatment for follicular neoplasms, with low incidences of disease progression and complications, while maintaining thyroid functio...
Current management of patients with noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) is lobectomy with close clinical follow-up. Because this entity is still young...